In the next 10 years, more than 100 novel product launches are expected to enter the rapidly evolving adult vaccines market. Amidst advancements in vaccines technology propelled by the COVID-19 pandemic, we are facing a new set of barriers in vaccination uptake in a population with historically low uptake and challenging logistical hurdles. Join ZS’s Adi Natu and Ryan Arvin and external experts in the space to reflect on the near-term landscape of adult vaccines, discuss the future of adult vaccination globally and deliberate on the potential role of combination vaccines in this arena.
Through this webinar, you will:
- Explore the current adult vaccination landscape globally, highlighting key disease areas of focus, potential upcoming launches and their implications for the broader industry
- Discover the greatest barriers (scientific, behavioral, logistical, etc.) facing uptake in the adult market and the roles of entities in the ecosystem to overcome those barriers
- Get a glimpse at the various perspectives on the potential role or limitations of combination vaccines in the adult market
Add insights to your inbox
We’ll send you content you’ll want to read – and put to use.
